NEW YORK (GenomeWeb) – OneOme announced today that it has signed an agreement to offer its RightMed pharmacogenomic test in Canada through medication management firm ProZed Pharmacy Solutions.

Under the terms of the deal, OneOme's PCR-based RightMed test — which covers 22 genes in which variants are known to contribute to the effectiveness or safety of more than 340 drugs for more than 20 indications — will be exclusively available to ProZed customers at Northern Shores Pharmacy in North Bay, Ontario.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.